| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,368 | 1,981 | 2,566 | 3,960 | | Cost of Revenue | 682 | 276 | 320 | 642 | | | Gross Profit | 2,686 | 1,705 | 2,246 | 3,318 | | | Operating Expenses | | Research Development | 5,668 | 4,072 | 3,829 | 4,156 | | Selling General and Administrative | 2,202 | 2,461 | 2,417 | 2,952 | | Non Recurring |
-
| 431 | 275 | 2,713 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (5,184) | (5,259) | (4,275) | (6,503) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 139 | 151 | 203 | 217 | | Earnings Before Interest And Taxes | (5,045) | (5,108) | (4,072) | (6,286) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (5,045) | (5,108) | (4,072) | (6,286) | | Income Tax Expense | 3 | 26 | 7 | 21 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,048) | (5,134) | (4,079) | (6,307) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,048) | (5,134) | (4,079) | (6,307) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,048) | ($5,134) | ($4,079) | ($6,307) |
|
0.51% Nasdaq 
Income Statement
